Ascendia
Kaoru Tominaga is a highly experienced formulation scientist currently serving as Principal Formulation Scientist at Ascendia since June 2021. Previously, Tominaga held the position of Senior Formulation Scientist at Aprecia Pharmaceuticals from December 2018 to May 2021, and during an extensive tenure at Ascendia Pharmaceuticals LLC from September 2013 to November 2018, progressed through roles including Senior Manager, Manager, and Senior Scientist. Tominaga's early career included a position as a Ph.D. student at Roche from 2010 to 2012. Educationally, Tominaga earned a Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences from the University of Rhode Island between 2006 and 2013.
Ascendia
1 followers
Ascendia Pharmaceuticals offers a comprehensive suite of pre-formulation for preclinical- and clinical-stage drug candidates. It specializes in improving the solubility and bioavailability of poorly water-soluble drugs using its suite of nanotechnology platforms. Ascendia formulates products for injectable, oral, and topical routes ofadministration. The company has three technology platforms - EmulSol for producing nano-emulsions, AmorSol for creating amorphous solid dispersions, and NanoSol for formulating nano-particles.